title: Ketamine followed by memantine for the treatment of major depression.
authors.forename: Rainer
authors.initials: R
authors.lastname: Kollmar
authors.forename: Katrin
authors.initials: K
authors.lastname: Markovic
authors.forename: Norbert
authors.initials: N
authors.lastname: Thürauf
authors.forename: Hubert
authors.initials: H
authors.lastname: Schmitt
authors.forename: Johannes
authors.initials: J
authors.lastname: Kornhuber
mesh_terms: D000284:Administration, Oral; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000523:psychology; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007649:Ketamine / Q000008:administration & dosage / Q000627:therapeutic use*; D008559:Memantine / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
chemical_list: D018691:Excitatory Amino Acid Antagonists; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D008559:Memantine